))
The strategic negotiations behind the Allergan-Actavis merger amidst Valeant's hostile takeover bid.
Manage episode 429559830 series 3489545
Contenido proporcionado por Yadvinder Singh Rana. Todo el contenido del podcast, incluidos episodios, gráficos y descripciones de podcast, lo carga y proporciona directamente Yadvinder Singh Rana o su socio de plataforma de podcast. Si cree que alguien está utilizando su trabajo protegido por derechos de autor sin su permiso, puede seguir el proceso descrito aquí https://es.player.fm/legal.
In this episode, we'll explore the 66 billion $ merger negotiations between Allergan and Actavis, and the hostile takeover attempt by Valeant.
Joining me again is my special co-host, Alex, an advanced Artificial Intelligence known as ChatGPT.
Alex brings a unique perspective to our analysis, harnessing the power of AI to deepen our conversation.
If you enjoyed this episode, please leave a review and check out our website: neglob.com
I welcome any suggestions, questions, or comments at yrana@neglob.com
--------------------------------------------------------------------------------------------------
Copyright Disclaimer Under Section 107 of the Copyright Act 1976, allowance is made for "fair use" for purposes such as criticism, comment, news reporting, teaching, scholarship, and research. Fair use is a use permitted by copyright statute that might otherwise be infringing.
8 episodios
Compartir
